Back to Search
Start Over
SOX9 promotes hypoxic pulmonary hypertension through stabilization of DPP4 in pulmonary artery smooth muscle cells.
- Source :
-
Experimental cell research [Exp Cell Res] 2024 Oct 01; Vol. 442 (2), pp. 114254. Date of Electronic Publication: 2024 Sep 12. - Publication Year :
- 2024
-
Abstract
- Pulmonary hypertension (PH) is a progressive cardiopulmonary disorder characterized by pulmonary vascular remodeling (PVR), primarily due to the excessive proliferation of pulmonary artery smooth muscle cells (PASMCs). This study aimed to investigate the role and molecular mechanism of SOX9 in hypoxic PH in rats. The findings revealed that SOX9 was upregulated in the pulmonary arteries and PASMCs of hypoxia-exposed rats. SOX9 knockdown inhibited hypoxia-induced proliferation and migration of PASMCs, reduced PVR, and subsequently alleviated hypoxia-induced PH in rats, suggesting that SOX9 plays a critical role in PH. Further investigation demonstrated that SOX9 interacted with DPP4, preventing its ubiquitin degradation in hypoxia-exposed PASMCs. DPP4 knockdown inhibited hypoxia-induced PASMC proliferation and migration, and administration of the DPP4 inhibitor sitagliptin (5 mg/kg) significantly reduced PVR and alleviated hypoxia-induced PH in rats, indicating that SOX9 contributes to PH by stabilizing DPP4. The results also showed that hypoxia induced YAP1 expression and dephosphorylation, leading to YAP1 nuclear localization. YAP1 knockdown promoted the degradation of HIF-1α in hypoxia-exposed PASMCs and inhibited hypoxia-induced proliferation and migration of PASMCs. Additionally, HIF-1α, as a transcription factor, promoted SOX9 expression by binding to the SOX9 promoter in hypoxia-exposed PASMCs. In conclusion, hypoxia promotes the proliferation and migration of PASMCs through the regulation of the YAP1/HIF-1α/SOX9/DPP4 signaling pathway, leading to PH in rats. These findings suggest that SOX9 may serve as a potential prognostic marker and therapeutic target for PH.<br />Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.<br /> (Copyright © 2024 Elsevier Inc. All rights reserved.)
- Subjects :
- Animals
Male
Rats
Cell Hypoxia
Cells, Cultured
Hypoxia metabolism
Hypoxia-Inducible Factor 1, alpha Subunit metabolism
Hypoxia-Inducible Factor 1, alpha Subunit genetics
Muscle, Smooth, Vascular metabolism
Muscle, Smooth, Vascular pathology
Rats, Sprague-Dawley
Signal Transduction
Vascular Remodeling
YAP-Signaling Proteins metabolism
Cell Movement
Cell Proliferation
Dipeptidyl Peptidase 4 metabolism
Dipeptidyl Peptidase 4 genetics
Hypertension, Pulmonary metabolism
Hypertension, Pulmonary pathology
Hypertension, Pulmonary genetics
Myocytes, Smooth Muscle metabolism
Myocytes, Smooth Muscle pathology
Pulmonary Artery metabolism
Pulmonary Artery pathology
SOX9 Transcription Factor metabolism
SOX9 Transcription Factor genetics
Subjects
Details
- Language :
- English
- ISSN :
- 1090-2422
- Volume :
- 442
- Issue :
- 2
- Database :
- MEDLINE
- Journal :
- Experimental cell research
- Publication Type :
- Academic Journal
- Accession number :
- 39276964
- Full Text :
- https://doi.org/10.1016/j.yexcr.2024.114254